226 summarised stories about AI & Healthcare, each linking back to the original source. Browse all topics →
TechCrunch 1 month ago 11 ● 10 sources
Apple unveiled the iPhone Duo foldable phone and updated iPhone, Apple Watch, AirPods, and Health products at its fall iPhone event.
TechCrunch 1 month ago 17 ● 4 sources
Apple introduced a redesigned Apple Health app alongside Apple Watch Series 12 and Ultra 4, adding an Insights tab plus personalized assessments and guidance using Apple Intelligence. It includes a readiness score and a “Health Age” calculation, and Apple is partnering with Quest for a 50-biomarker panel priced at $119. The app adds a longevity tab and can incorporate lab results, and it will roll out later this year starting in U.S. English.
Ars Technica 1 month ago 4 ● 6 sources
Google announced AlphaGenome Atlas, a system meant to predict the effects of every possible single-base change in the human genome. It scales the work to about 9 billion one-base variants by checking three alternate bases across roughly 3 billion reference positions. This provides a single software resource for evaluating non-coding DNA functions, which may speed up how biologists identify regulatory sequence variants.
Tech.eu 1 month ago 40
MSK Innovation Accelerator opened applications for its fourth six-month programme dedicated to musculoskeletal innovation in the UK. Each fully funded venture receives more than £80,000 of specialist support, and applications close on 4 October 2026. The accelerator adds a focus area that welcomes AI-related work and offers pitching for investment, with continued support to move technologies from research toward commercialisation.
Tech Funding News 1 month ago 3
Implicity raised €35M from IRIS and Five Arrows to scale its AI platform for cardiac monitoring, which ties to a patient mortality reduction. The funding follows a reported 26% reduction in patient mortality. The company plans to expand in the United States and pursue acquisitions, while adding teams in the US and Germany.
Tech Funding News 1 month ago 31
Forus raised a $150 million Series C round led by Bain Capital Ventures, tripling its valuation to $3 billion in four months. The company’s AI agent network reaches patients in 85% of US residential ZIP codes across all 50 states. Forus will use the funding to expand into more specialties and care settings and add capabilities to its per-prescription AI agents, aiming to speed the paperwork and start of high-cost or complex treatments.
Tech.eu 1 month ago 34
Anemo Labs raised £700,000 in pre-seed funding to develop an electronic nose that detects disease-related volatile organic compounds from body emissions. In early tests, its machine-learning models classified scent categories 84.15% across 12 categories using the Sniffin' Sticks protocol. The company will use the funding to expand its smell data collection and sensor development and to continue clinical validation for urine-based, non-invasive screening.
IBM Research 1 month ago 39
Cleveland Clinic, RIKEN, and IBM were named 2026 ACM Gordon Bell Prize finalists for quantum-HPC chemistry research involving protein simulations. The work modeled a 12,635-atom protein system using IBM Quantum Heron processors integrated with supercomputers Fugaku, RUQUO, and Miyabi-G. Their new fully automated end-to-end workflow on RIKEN’s ROQUO reduces manual coordination and data movement while improving protein-ligand binding energy accuracy.
The daily briefing
TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.
TLDRocket
17 October 2026
The big thread today is the messy middle between agent ambitions and the boring parts that make them safe and auditable. ServiceNow is positioning its AI Control Tower as the enterprise hub to discover, govern, and—crucially—control AI agents across models and clouds, while a field study of 15 large-enterprise customers (conducted September 15–21, 2026) presses on a key question: how strong is “technical runtime enforcement” and lifecycle evidence compared with other tools? ServiceNow’s answer is mostly commercial muscle—aiming for $1.5B in full-year AI ACV—but its guidance effectively says buyers should treat Control Tower as strongest for governance workflows and operational action, then verify where model validation evidence and real-time blocking are actually handled.
Read the full briefing →